Universe Pharmaceuticals Faces $13.1M Loss Amidst Revenue Decline
Universe Pharmaceuticals reports a $13.1M loss for 2024's first half, with revenue falling by 30.2% amidst global economic challenges.
- Latest
- Trending
Universe Pharmaceuticals reports a $13.1M loss for 2024's first half, with revenue falling by 30.2% amidst global economic challenges.
Investors of DXC Technology are urged to join class action for alleged securities fraud between May 2021 and May 2024.
Explore the legal implications, potential liabilities, and strategies to manage cybersecurity risks in the age of Industry 4.0.
Marvell Technology declares $0.06 dividend per share, payable on October 31, 2024.
Taishin increases Shin Kong bid by 25%, marking Taiwan's largest financial merger; CTBC's rival bid adds uncertainty.
Deutsche Bank gives Buy ratings to Star Bulk and Genco, citing strong fundamentals and attractive valuations in maritime shipping.
Berkshire Hathaway sells $228.7M in BofA shares, continues reducing stake. Total sales since July reach $7.19B.
WH Smith shares increase by 12.3% after a 7% annual revenue rise, driven by travel demand resurgence.
Nike investors vote against supply chain worker agreements, despite pressure over human rights concerns.
TPG RE Finance Trust announces $0.3906 dividend for Series C Preferred Stock, payable Sept 30, 2024.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.